申请人:TEVA PHARMA
公开号:WO2011087791A1
公开(公告)日:2011-07-21
The subject invention provides a pharmaceutical composition containing N-ρropargyl-l(R)- ammoindan or a pharmaceutically acceptable salt thereof, and a compound of 3 keto N proρargyl-1-aminoindan or a salt thereof